Literature DB >> 15713474

Structural characterization of the cell wall binding domains of Clostridium difficile toxins A and B; evidence that Ca2+ plays a role in toxin A cell surface association.

Stephen J Demarest1, Jared Salbato, Marikka Elia, Jingping Zhong, Theresa Morrow, Trevin Holland, Katie Kline, Gary Woodnutt, Bruce E Kimmel, Geneviève Hansen.   

Abstract

Clostridium difficile (C.difficile) is a nosocomially acquired intestinal bacillus which can cause chronic diarrhea and life-threatening colitis. The pathogenic effects of the bacillus are mediated by the release of two toxins, A and B. The C-terminal portions of both toxins are composed of 20 and 30 residue repeats known as cell wall binding (CWB) domains. We have cloned and expressed the CWB-domains of toxins A and B and several truncated CWB-domain constructs to investigate their structure and function. The smallest CWB-domain that folded in a cooperative manner was an 11 repeat construct of toxin A. This differentiates the C-terminal domains of toxins A and B from the CWB-domain of Streptococcus pneumoniae LytA, which only requires six repeats to fold. The 11 repeat toxin A construct bound Ca2+ directly with millimolar affinity and interacted with mammalian cell surfaces in a concentration and Ca2+-dependent fashion. Millimolar Ca2+ levels also accelerated toxin mediated CHO cell killing in an in vitro cell assay. Together, the data suggest a role for extracellular Ca2+ in the sensitization of toxin A/cell-surface interactions.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15713474     DOI: 10.1016/j.jmb.2004.12.059

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Crystal structure of receptor-binding C-terminal repeats from Clostridium difficile toxin A.

Authors:  Jason G S Ho; Antonio Greco; Maja Rupnik; Kenneth K-S Ng
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-12       Impact factor: 11.205

Review 2.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

3.  Effective Sequestration of Clostridium difficile Protein Toxins by Calcium Aluminosilicate.

Authors:  Joseph M Sturino; Karina Pokusaeva; Robert Carpenter
Journal:  Antimicrob Agents Chemother       Date:  2015-07-06       Impact factor: 5.191

4.  Neutralization of Clostridium difficile toxin A using antibody combinations.

Authors:  Stephen J Demarest; Mangala Hariharan; Marikka Elia; Jared Salbato; Ping Jin; Colin Bird; Jay M Short; Bruce E Kimmel; Michael Dudley; Gary Woodnutt; Geneviève Hansen
Journal:  MAbs       Date:  2010 Mar-Apr       Impact factor: 5.857

5.  C-terminal repeats of Clostridium difficile toxin A induce production of chemokine and adhesion molecules in endothelial cells and promote migration of leukocytes.

Authors:  Chiou-Yueh Yeh; Chun-Nan Lin; Chuan-Fa Chang; Chun-Hung Lin; Huei-Ting Lien; Jen-Yang Chen; Jean-San Chia
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

6.  The repetitive oligopeptide sequences modulate cytopathic potency but are not crucial for cellular uptake of Clostridium difficile toxin A.

Authors:  Alexandra Olling; Sebastian Goy; Florian Hoffmann; Helma Tatge; Ingo Just; Ralf Gerhard
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

Review 7.  Clostridium difficile Toxins A and B: Insights into Pathogenic Properties and Extraintestinal Effects.

Authors:  Stefano Di Bella; Paolo Ascenzi; Steven Siarakas; Nicola Petrosillo; Alessandra di Masi
Journal:  Toxins (Basel)       Date:  2016-05-03       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.